Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

SHE:300832 Revenue

Shenzhen New Industries Biomedical Engineering had revenue of 1.28B CNY in the quarter ending September 30, 2026, with 3.03% growth. This brings the company's total for the last twelve months to 4.85B, up 6.62% year-over-year. In the year 2025, Shenzhen New Industries Biomedical Engineering had annual revenue of 4.58B with 0.91% growth. That makes Shenzhen New Industries Biomedical Engineering the 9,219th largest company in the world by revenue and 1,460th in China.

• Revenue (ttm): 4.85B
• Revenue Growth: +6.62%
• P/S Ratio: 9.81
• Revenue / Employee: 1.74M
• Employees: 2,785
• Market Cap: 47.58B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• In Vitro Diagnostic 4.57B 99.9%
• Unallocated Other Business 6.08M 0.1%

By Geography

Chart

• China 2.57B 56.1%
• Foreign 2.01B 43.9%

Fiscal year ended Dec 31, 2025 See the full SHE:300832 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.58B	41.36M	0.91%
Dec 31, 2024	4.54B	605.75M	15.41%
Dec 31, 2023	3.93B	882.70M	28.97%
Jan 1, 2023	3.05B	501.54M	19.70%
Jan 1, 2022	2.55B	350.45M	15.97%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error